Cameron McAulay - 15 Dec 2021 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Chief Financial Officer
Signature
/s/ Cameron McAulay
Issuer symbol
TGAN
Transactions as of
15 Dec 2021
Transactions value $
$0
Form type
4
Filing time
17 Dec 2021, 15:10:14 UTC
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +22K +28.52% $0.00 99.1K 15 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TGAN Stock Option (right to buy) Award $0 +33K $0.00 33K 15 Dec 2021 Common Stock 33K $7.99 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). One third (1/3) of the RSUs will vest on each of November 15, 2022, November 15, 2023 and November 15, 2024, in each case subject to the Reporting Person's continued status as a Service Provider to the Issuer through each vesting date.
F2 One-third (1/3) of the shares subject to the option will vest on November 15, 2022, and the remaining shares vest in equal monthly installments over the following 24 months, subject to the Reporting Person's continued service as of each such vesting date.